Severe infections caused by difficult-to-treat Gram-negative bacteria.

Authors:
Dettori S; Portunato F; Vena A; Giacobbe DR; Bassetti M.

Journal:
Curr Opin Crit Care

Publication Year: 2023

DOI:
10.1097/MCC.0000000000001074

PMCID:
PMC10919274

PMID:
37641512

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Curr Opin Crit Care

Abbreviation: Curr Opin Crit Care

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Critical Care

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Critical illness-associated limb and diaphragmatic weakness.
Le Stang V; Latronico N; Dres M and 1 more (2024) - Transparency Score: 3/6
Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest - current status.
Suverein MM; Maessen JG; van de Poll MCG. (2023) - Transparency Score: 3/6
Neurological complications of sepsis.
Piva S; Bertoni M; Gitti N and 2 more (2023) - Transparency Score: 3/6
Nutritional strategies during gastrointestinal dysfunction.
van Gassel RJJ; Bels JLM; van de Poll MCG. (2023) - Transparency Score: 3/6
Nutrition and autophagy deficiency in critical illness.
Vanhorebeek I; Casaer M; Gunst J. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest M.B. has participated in the past 5 years in advisory boards, research grants and/or received speaker bureau from Astellas, Pfizer, MSD, Gilead, Angelini, Bayer, Biomerieux, Cidara, Menarini, and Shionogi. The other authors declare no conflicts of interest. M.B. has participated in the past 5 years in advisory boards, research grants and/or received speaker bureau from Astellas, Pfizer, MSD, Gilead, Angelini, Bayer, Biomerieux, Cidara, Menarini, and Shionogi. The other authors declare no conflicts of interest."

Evidence found in paper:

"Financial support and sponsorship None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025